Agenus Announces First Patient Dosed in Phase 1 Study of AGEN1571 (anti-ILT2) in Advanced Solid Tumors
Study will evaluate safety and tolerability of AGEN1571 as a single agent and in combination with botensilimab and balstilimab Preclinical...
News
Surgalign Schedules Second Quarter 2022 Earnings Release for August 9, 2022
DEERFIELD, Ill., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on...
CorMedix Inc. To Report Second Quarter 2022 Financial Results and Provide a Corporate Update on August 11
BERKELEY HEIGHTS, N.J., Aug. 01, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Avelead Expands Agreement with Large Provider Network for Compare Solution
National Health System Chooses Compare Solution to Assist with EHR Conversions and Enhance Data Quality Atlanta, GA, Aug. 01, 2022...
ALR Technologies Announces First Shipment of GluCurve Pet CGMs Expected in October and Update on the Manufacturing Agreement
SINGAPORE, Aug. 01, 2022 (GLOBE NEWSWIRE) -- ALR Technologies SG Pte. Ltd (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes...
Exhale Wellness Expands Its Product Line With The Launch Of Delta 9 Gummies & Drops
The manufacturer and distributor of hemp-derived products announces the launch of its newest offering, the Delta-9 gummies range, which is...
Palisade Bio Launches New Corporate Website and Reiterates Commitment to Develop Therapeutics that Protect Intestinal Barrier Health
New website aligns with company’s mission to become a global leader in addressing diseases linked to intestinal barrier disruption and...
Teladoc Health Is Providing Free Virtual Health Care Services to Those Impacted by Kentucky Flooding
PURCHASE, NY, July 30, 2022 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, is...
Financière de Tubize – 2022 half-year financial report
Press release30 July 2022Embargo till 08:00h CET FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Brussels Contact: Eric...
Neovasc to Report Second Quarter Financial Results on August 11, 2022
VANCOUVER and MINNEAPOLIS, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (NASDAQ , TSX : NVCN), will...
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
Proceeds Will Be Used to Grow CURE’s Wellness and Beauty Brands and Its Remaining Proprietary Platform TechnologyOXNARD, Calif., July 28,...
Altamira Therapeutics’ Delivery Platform with siRNA Shown to be Effective Treatment for Osteoarthritis as Published in Peer-Reviewed Journal
•Independent peer-reviewed study confirms high potential for OligoPhoreTM delivery platform in RNA-based treatments for osteoarthritis •Knock down of JMJD3 gene...
Best CBD Products By Exhale Wellness: Buy Oils, Gummies & Vapes (A Complete Guide)
GLENDALE, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- The farm bill of 2018 legalized the use of CBD with less...
Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease
Phase 2a trial initiation planned for the first half of 2023 subject to IND clearance and available capitalNEWTON, Mass. and...
Sientra to Report Second Quarter 2022 Financial Results on August 11, 2022
SANTA BARBARA, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company...
Streamline Health® eValuator™ Debuts Pro-Fee Module
Addition Creates a Single Pre-Bill Coding Optimization Platform Spanning Inpatient, Outpatient and Professional Fee Services Atlanta, GA, July 28, 2022...
Veru to Report Fiscal 2022 Third Quarter Financial Results, Host Conference Call on August 11th
MIAMI, July 28, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for...
Wave Life Sciences to Webcast Conference Call of Second Quarter 2022 Financial Results on August 11, 2022
CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed...
Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Review of NDA Resubmission for ACER-001 for Treatment of UCDs
Prescription Drug User Fee Act (PDUFA) target action date set for January 15, 2023NEWTON, Mass. and GENEVA, July 28, 2022...
Quoin Pharmaceuticals Announces Receipt of Constructive Scientific Advice from EMA for QRX003 Development in Europe
EMA Guidance Provides Clear Path Forward for Quoin’s Netherton Syndrome Product in EuropeASHBURN, Va., July 28, 2022 (GLOBE NEWSWIRE) --...